Cargando…

Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies

Royal jelly (RJ) is a glandular secretion produced by worker honeybees and is a special food for the queen honeybee. It results in a significant prolongation of the lifespan of the queen honeybee compared with the worker honeybees through anti-inflammatory, anti-oxidant and anti-microbial activities...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata, Yasuyoshi, Sakai, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214034/
https://www.ncbi.nlm.nih.gov/pubmed/30347885
http://dx.doi.org/10.3390/ijms19103270
_version_ 1783367915383291904
author Miyata, Yasuyoshi
Sakai, Hideki
author_facet Miyata, Yasuyoshi
Sakai, Hideki
author_sort Miyata, Yasuyoshi
collection PubMed
description Royal jelly (RJ) is a glandular secretion produced by worker honeybees and is a special food for the queen honeybee. It results in a significant prolongation of the lifespan of the queen honeybee compared with the worker honeybees through anti-inflammatory, anti-oxidant and anti-microbial activities. Consequently, RJ is used as cosmetic and dietary supplement throughout the world. In addition, in vitro studies and animal experiments have demonstrated that RJ inhibits cell proliferation and stimulates apoptosis in various types of malignant cells and affects the production of various chemokines, anti-oxidants and growth factors and the expression of cancer-related molecules in patients with malignancies, especially in patients treated with anti-cancer agents. Therefore, RJ is thought to exert anti-cancer effects on tumor growth and exhibit protective functions against drug-induced toxicities. RJ has also been demonstrated to be useful for suppression of adverse events, the maintenance of the quality of life during treatment and the improvement of prognosis in animal models and patients with malignancies. To understand the mechanisms of the beneficial effects of RJ, knowledge of the changes induced at the molecular level by RJ with respect to cell survival, inflammation, oxidative stress and other cancer-related factors is essential. In addition, the effects of combination therapies of RJ and other anti-cancer agents or natural compounds are important to determine the future direction of RJ-based treatment strategies. Therefore, in this review, we have covered the following five issues: (1) the anti-cancer effects of RJ and its main component, 10-hydroxy-2-decenoic acid; (2) the protective effects of RJ against anti-cancer agent-induced toxicities; (3) the molecular mechanisms of such beneficial effects of RJ; (4) the safety and toxicity of RJ; and (5) the future directions of RJ-based treatment strategies, with a discussion on the limitations of the study of the biological activities of RJ.
format Online
Article
Text
id pubmed-6214034
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62140342018-11-14 Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies Miyata, Yasuyoshi Sakai, Hideki Int J Mol Sci Review Royal jelly (RJ) is a glandular secretion produced by worker honeybees and is a special food for the queen honeybee. It results in a significant prolongation of the lifespan of the queen honeybee compared with the worker honeybees through anti-inflammatory, anti-oxidant and anti-microbial activities. Consequently, RJ is used as cosmetic and dietary supplement throughout the world. In addition, in vitro studies and animal experiments have demonstrated that RJ inhibits cell proliferation and stimulates apoptosis in various types of malignant cells and affects the production of various chemokines, anti-oxidants and growth factors and the expression of cancer-related molecules in patients with malignancies, especially in patients treated with anti-cancer agents. Therefore, RJ is thought to exert anti-cancer effects on tumor growth and exhibit protective functions against drug-induced toxicities. RJ has also been demonstrated to be useful for suppression of adverse events, the maintenance of the quality of life during treatment and the improvement of prognosis in animal models and patients with malignancies. To understand the mechanisms of the beneficial effects of RJ, knowledge of the changes induced at the molecular level by RJ with respect to cell survival, inflammation, oxidative stress and other cancer-related factors is essential. In addition, the effects of combination therapies of RJ and other anti-cancer agents or natural compounds are important to determine the future direction of RJ-based treatment strategies. Therefore, in this review, we have covered the following five issues: (1) the anti-cancer effects of RJ and its main component, 10-hydroxy-2-decenoic acid; (2) the protective effects of RJ against anti-cancer agent-induced toxicities; (3) the molecular mechanisms of such beneficial effects of RJ; (4) the safety and toxicity of RJ; and (5) the future directions of RJ-based treatment strategies, with a discussion on the limitations of the study of the biological activities of RJ. MDPI 2018-10-21 /pmc/articles/PMC6214034/ /pubmed/30347885 http://dx.doi.org/10.3390/ijms19103270 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Miyata, Yasuyoshi
Sakai, Hideki
Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies
title Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies
title_full Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies
title_fullStr Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies
title_full_unstemmed Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies
title_short Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies
title_sort anti-cancer and protective effects of royal jelly for therapy-induced toxicities in malignancies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214034/
https://www.ncbi.nlm.nih.gov/pubmed/30347885
http://dx.doi.org/10.3390/ijms19103270
work_keys_str_mv AT miyatayasuyoshi anticancerandprotectiveeffectsofroyaljellyfortherapyinducedtoxicitiesinmalignancies
AT sakaihideki anticancerandprotectiveeffectsofroyaljellyfortherapyinducedtoxicitiesinmalignancies